This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SBPH Spring Bank Pharmaceuticals (SBPH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Spring Bank Pharmaceuticals Stock (NASDAQ:SBPH) 30 days 90 days 365 days Advanced Chart Get SBPH alerts:Sign Up Key Stats Today's Range N/A50-Day Range$1.21▼$10.3952-Week Range N/AVolumeN/AAverage Volume177,606 shsMarket Capitalization$122.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSpring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of a range of cancers and inflammatory diseases using its proprietary small molecule nucleotide platform. The company is developing SB 11285, a next-generation immunotherapeutic cyclic dinucleotide for the treatment of selected cancers; novel STING antagonist compounds for the treatment of autoimmune and inflammatory diseases; and novel platform to enable the targeted delivery of payload molecules. It has a collaboration agreement with with Roche to explore the co-administration of SB 11285. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts.Read More… Receive SBPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spring Bank Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address SBPH Stock News HeadlinesCapital One Bank ReviewOctober 18, 2024 | marketwatch.comDiscover Bank Review (August 2024)August 8, 2024 | marketwatch.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. June 30 at 2:00 AM | Porter & Company (Ad)How many bank holidays are in May? How to get the most from your holiday allowanceMay 10, 2024 | uk.finance.yahoo.comSupermarket May bank holiday opening times 2024 including Tesco, Aldi, Morrisons and moreMay 6, 2024 | mirror.co.ukMWhen will interest rates go down?January 31, 2024 | thetimes.co.ukTBank of Canada expected to 'cautiously' start cutting rates in spring: Deloitte CanadaJanuary 6, 2024 | ca.finance.yahoo.comMan stabbed during street fight in Spring Bank WestSeptember 29, 2023 | hulldailymail.co.ukSee More Headlines SBPH Stock Analysis - Frequently Asked Questions How were Spring Bank Pharmaceuticals' earnings last quarter? Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) announced its earnings results on Sunday, November, 8th. The company reported ($0.31) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.06. When did Spring Bank Pharmaceuticals IPO? Spring Bank Pharmaceuticals (SBPH) raised $14 million in an IPO on Friday, May 6th 2016. The company issued 1,100,000 shares at $12.00-$14.00 per share. Dawson James Securities served as the underwriter for the IPO. What other stocks do shareholders of Spring Bank Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Spring Bank Pharmaceuticals investors own include Intelsat (I), AMC Entertainment (AMC), Bank of America (BAC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO) and Chaarat Gold (CGH). Company Calendar Last Earnings11/08/2020Today6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SBPH CIK1566373 Webwww.springbankpharm.com Phone508-473-5993FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$24.10 million Net MarginsN/A Pretax MarginN/A Return on Equity-89.89% Return on Assets-52.89% Debt Debt-to-Equity RatioN/A Current Ratio5.11 Quick Ratio5.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.16 per share Price / BookN/AMiscellaneous Outstanding Shares17,267,000Free FloatN/AMarket Cap$122.94 million OptionableNot Optionable Beta1.07 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SBPH) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spring Bank Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spring Bank Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.